MD Anderson and C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy
Newswise — HOUSTON & POHANG, South Korea – The University of Texas MD Anderson Cancer Center and C-Biomex Ltd. today announced a strategic research collaboration agreement to co-develop CBT-001,…
Read more MD Anderson and C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy